Navigation Links
Heska Introduces New Lactate Meter Analyzer
Date:3/1/2011

LOVELAND, Colo., March 1, 2011 /PRNewswire/ -- Heska Corporation (Nasdaq: HSKA; "Heska"), a leading provider of advanced diagnostic and specialty products to veterinarians, today announced the addition of a lactate meter analyzer to its portfolio of in-clinic blood analyzers.

(Logo:  http://photos.prnewswire.com/prnh/20000622/HESKALOGO)

Among other features, the handheld portable analyzer is used to measure lactate, and is ideal for both in-clinic and field use. It provides a lactate assay solution to complement the VitalPath® and DRI-CHEM® Analyzers for complete blood analysis.

"Heska is pleased to announce another product collaboration with Roche," commented Michael McGinley, President and Chief Operating Officer of Heska. "This new lactate meter analyzer will complement Heska's full range of blood analyzers, and is another example of our commitment to innovation within the veterinary industry."

About Heska

Heska Corporation (Nasdaq: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic and monitoring instruments and supplies as well as single use, point-of-care tests, vaccines and pharmaceuticals. The company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at www.heska.com.

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are based on current expectations and are subject to a number of risks and uncertainties including risks related to Heska's reliance on a third party, Roche Diagnostics, to supply the lactate meter analyzers and affiliated consumables of appropriate quality and quantity; competition; uncertainties regarding Heska's ability to successfully commercialize new products; uncertainties regarding Heska's ability to market, sell and distribute products; uncertainties regarding the performance of products in field use as compared to current expectations; uncertainties regarding the outcome of any collaborations between Heska and any third party, including Roche; risks related to relying on the reputation of Heska, Roche or any other entity, which is subject to interpretation and may change over time; uncertainties related to the future development efforts of any third party; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Annual Report on Form 10-K/A for the year ended December 31, 2009 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2010.


'/>"/>
SOURCE Heska Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Heska to Present Live, Online at RetailInvestorConferences.com
2. Heska to Present at Sidoti Micro-Cap Conference
3. Heska Corporation Announces Stockholder Approval of Reverse Split
4. Webcast Alert: Heska Corporations Special Meeting of Stockholders Webcast
5. Heska Corporation Awards $25,000 Grand Prize to Pets Forever
6. Heska Announces Q310 Results
7. Heska Announces First Installation of New Blood Gas & Electrolyte Analyzer
8. Heska to Present at SunTrust Robinson Humphrey 1st Annual Veterinary Conference
9. Webcast Alert: Heska Announces Fourth Quarter and Year-End 2009 Earnings Conference Call Webcast
10. Heska Announces Extension of Credit Agreement With Wells Fargo
11. Heska Announces Supply Agreement With Roche Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
Breaking Medicine News(10 mins):